Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8421) 8421
Book Chapter (60) 60
Newsletter (47) 47
Magazine Article (44) 44
Book / eBook (19) 19
Newspaper Article (18) 18
Conference Proceeding (9) 9
Dissertation (3) 3
Web Resource (3) 3
Transcript (2) 2
Government Document (1) 1
Publication (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6124) 6124
science & technology (5856) 5856
life sciences & biomedicine (5426) 5426
male (3897) 3897
purines (3209) 3209
sildenafil citrate (2841) 2841
animals (2513) 2513
piperazines - therapeutic use (2312) 2312
female (2096) 2096
biological and medical sciences (2037) 2037
medical sciences (1895) 1895
purines - therapeutic use (1859) 1859
middle aged (1763) 1763
adult (1528) 1528
sulfones (1423) 1423
aged (1208) 1208
erectile dysfunction - drug therapy (1176) 1176
pharmacology & pharmacy (1176) 1176
purines - pharmacology (1109) 1109
sildenafil (1071) 1071
phosphodiesterase inhibitors - therapeutic use (1055) 1055
treatment outcome (1006) 1006
sulfones - therapeutic use (988) 988
mice (867) 867
vasodilator agents - therapeutic use (839) 839
pharmacology. drug treatments (803) 803
rats (787) 787
analysis (744) 744
abridged index medicus (740) 740
oncology (641) 641
piperazines - pharmacology (603) 603
urology & nephrology (596) 596
care and treatment (580) 580
research (552) 552
neurosciences & neurology (533) 533
hypertension, pulmonary - drug therapy (529) 529
drug therapy (523) 523
biochemistry & molecular biology (522) 522
neurosciences (516) 516
health aspects (515) 515
purines - administration & dosage (515) 515
purines - metabolism (512) 512
piperazines - adverse effects (502) 502
dose-response relationship, drug (494) 494
erectile dysfunction (468) 468
piperazines - administration & dosage (452) 452
physiological aspects (445) 445
cancer (441) 441
antineoplastic agents - therapeutic use (435) 435
proteins (434) 434
purines - adverse effects (422) 422
cardiovascular system & cardiology (418) 418
time factors (407) 407
medicine & public health (404) 404
cell biology (400) 400
impotence (397) 397
disease models, animal (396) 396
enzymes (390) 390
general & internal medicine (390) 390
research article (384) 384
cardiac & cardiovascular systems (373) 373
chemistry (369) 369
risk factors (367) 367
drug therapy, combination (365) 365
adolescent (363) 363
science & technology - other topics (353) 353
nitric oxide (349) 349
apoptosis (348) 348
cell line, tumor (342) 342
double-blind method (341) 341
erectile dysfunction - etiology (341) 341
medicine (341) 341
adenosine (337) 337
multidisciplinary sciences (336) 336
medicine, general & internal (326) 326
sulfones - pharmacology (325) 325
metabolic diseases (323) 323
aged, 80 and over (313) 313
rats, sprague-dawley (313) 313
child (311) 311
gout (301) 301
hematology (301) 301
fundamental and applied biological sciences. psychology (296) 296
oxidases (295) 295
administration, oral (294) 294
kinases (294) 294
uric acid - blood (294) 294
pulmonary hypertension (293) 293
physical sciences (292) 292
neurology (289) 289
other metabolic disorders (282) 282
purines and pyrimidines (282) 282
rodents (282) 282
signal transduction (276) 276
phosphodiesterase inhibitors - pharmacology (275) 275
biomedicine (272) 272
purines - chemistry (270) 270
gene expression (268) 268
inflammation (267) 267
metabolism (264) 264
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (13) 13
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7978) 7978
German (342) 342
French (84) 84
Japanese (70) 70
Spanish (57) 57
Chinese (50) 50
Russian (45) 45
Italian (38) 38
Portuguese (20) 20
Polish (19) 19
Danish (10) 10
Dutch (10) 10
Hebrew (8) 8
Hungarian (7) 7
Norwegian (6) 6
Swedish (6) 6
Finnish (5) 5
Ukrainian (5) 5
Czech (4) 4
Romanian (3) 3
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature
by Bajwah, Sabrina and Ross, Joy R and Peacock, Janet L and Higginson, Irene J and Wells, Athol U and Patel, Amit Suresh and Koffman, Jonathan and Riley, Julia
Thorax, ISSN 0040-6376, 09/2013, Volume 68, Issue 9, pp. 867 - 879
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Sulfones - therapeutic use | Glucocorticoids - therapeutic use | Cough - drug therapy | Colchicine - therapeutic use | Humans | Narcotics - therapeutic use | Dyspnea - etiology | Sildenafil Citrate | Anti-Bacterial Agents - therapeutic use | Exercise Test | Prednisolone - therapeutic use | Purines - therapeutic use | Lung - pathology | Piperazines - therapeutic use | Lung Diseases, Interstitial - complications | Lung Diseases, Interstitial - drug therapy | Oxygen Inhalation Therapy | Tubulin Modulators - therapeutic use | Cough - etiology | Heroin - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Lung Diseases, Interstitial - rehabilitation | Fibrosis | Quality of Life | Dyspnea - drug therapy | Pyridones - therapeutic use | Thalidomide - therapeutic use | Immunologic Factors - therapeutic use | Symptomatology | Lung diseases, Interstitial | Care and treatment | Research | Quality of life | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
by Scheen, A.J
Diabetes & metabolism, ISSN 1262-3636, 2011, Volume 38, Issue 2, pp. 89 - 101
Internal Medicine | Endocrinology & Metabolism | Linagliptine | Sitagliptin | Type 2 diabetes mellitus | Review | Clinical trial-DPP-4 inhibitor | Vildagliptine | Saxagliptine | Diabète de type 2 | Inhibiteur de la DPP-4 | Alogliptin | Sitagliptine | Linagliptin | Vildagliptin | Alogliptine | Revue générale | Essai clinique | Saxagliptin | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Metformin - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Glycated Hemoglobin A - drug effects | Male | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Adamantane - therapeutic use | Female | Weight Gain - drug effects | Purines - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Dipeptides - therapeutic use | Uracil - therapeutic use | Clinical Trials as Topic | Diabetes Mellitus, Type 2 - blood | Piperidines - therapeutic use | Quinazolines - therapeutic use | Cost-Benefit Analysis | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - therapeutic use | Uracil - analogs & derivatives | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Noninsulin glucose-lowering agents for the treatment of patients on dialysis
by Flynn, Colleen and Bakris, George L
Nature reviews. Nephrology, ISSN 1759-5061, 03/2013, Volume 9, Issue 3, pp. 147 - 153
Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Glycoside Hydrolase Inhibitors | Meglumine - therapeutic use | Metformin - therapeutic use | Biguanides - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Pyrazines - therapeutic use | Diabetic Nephropathies - therapy | Pyrrolidines - therapeutic use | Renal Insufficiency, Chronic - drug therapy | Renal Insufficiency, Chronic - therapy | Thiazolidinediones - therapeutic use | Adamantane - therapeutic use | Linagliptin | Purines - therapeutic use | Sitagliptin Phosphate | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Dipeptides - therapeutic use | Sulfonylurea Compounds - therapeutic use | Uracil - therapeutic use | Treatment Outcome | Disease Progression | Piperidines - therapeutic use | Quinazolines - therapeutic use | Glucagon-Like Peptides - therapeutic use | Nitriles - therapeutic use | Renal Dialysis | Uracil - analogs & derivatives | Diabetics | Care and treatment | Prognosis | Chronic kidney failure | Diagnosis | Research | Risk factors | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
by Gacci, Mauro and Corona, Giovanni and Salvi, Matteo and Vignozzi, Linda and McVary, Kevin T and Kaplan, Steven A and Roehrborn, Claus G and Serni, Sergio and Mirone, Vincenzo and Carini, Marco and Maggi, Mario
European urology, ISSN 0302-2838, 2012, Volume 61, Issue 5, pp. 994 - 1003
Urology | PDE5 | PDE5-I | IIEF | IPSS | Benign prostatic hyperplasia | Erectile dysfunction | BPH | LUTS | Lower urinary tract symptoms | Prostate | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Sulfones - therapeutic use | Triazines - therapeutic use | Humans | Adrenergic alpha-Antagonists - therapeutic use | Male | Treatment Outcome | Piperazines - therapeutic use | Sildenafil Citrate | Tadalafil | Lower Urinary Tract Symptoms - drug therapy | Sulfonamides - therapeutic use | Erectile Dysfunction - drug therapy | Pyrimidines - therapeutic use | Vardenafil Dihydrochloride | Phosphodiesterase 5 Inhibitors - therapeutic use | Purines - therapeutic use | Imidazoles - therapeutic use | Drug Therapy, Combination | Carbolines - therapeutic use | Prostatic Hyperplasia - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The protease inhibitor, GS‐9256, and non‐nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C
by Zeuzem, Stefan and Buggisch, Peter and Agarwal, Kosh and Marcellin, Patrick and Sereni, Daniel and Klinker, Hartwig and Moreno, Christophe and Zarski, Jean‐Pierre and Horsmans, Yves and Mo, Hongmei and Arterburn, Sarah and Knox, Steven and Oldach, David and McHutchison, John G and Manns, Michael P and Foster, Graham R
Hepatology (Baltimore, Md.), ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 749 - 758
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Middle Aged | Phosphinic Acids - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hepacivirus - genetics | Genotype | Male | RNA, Viral - blood | Treatment Outcome | Enzyme Inhibitors - therapeutic use | Polyethylene Glycols - therapeutic use | Dose-Response Relationship, Drug | Hepatitis C - blood | Peptides, Cyclic - therapeutic use | Adult | Female | Purines - therapeutic use | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Pyridazines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Novel Agents in the Treatment of Chronic Lymphocytic Leukemia: A Review About the Future
by Desai, Anjali Varma and El-Bakkar, Hassan and Abdul-Hay, Maher
Clinical lymphoma, myeloma and leukemia, ISSN 2152-2650, 2015, Volume 15, Issue 6, pp. 314 - 322
Hematology, Oncology and Palliative Medicine | CDK inhibitors | PI3K inhibitors | B cell lymphoma 2 inhibitors | Immunomodulators | Bruton tyrosine kinase inhibitors | CDK inhibitors | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Pyrazoles - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Lenalidomide | Humans | Pyridinium Compounds - therapeutic use | Receptors, Antigen, T-Cell - therapeutic use | Antineoplastic Agents - therapeutic use | Flavonoids - therapeutic use | Thalidomide - analogs & derivatives | Sulfonamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Isoquinolines - therapeutic use | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Purines - therapeutic use | Aniline Compounds - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Quinazolinones - therapeutic use | Thalidomide - therapeutic use | Immunologic Factors - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Eisenmenger Syndrome. A Clinical Perspective in a New Therapeutic Era of Pulmonary Arterial Hypertension
by Beghetti, Maurice and Galiè, Nazzareno
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2009, Volume 53, Issue 9, pp. 733 - 740
physiopathology | Eisenmenger syndrome | pulmonary arterial hypertension | therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Congenital heart diseases. Malformations of the aorta, pulmonary vessels and vena cava | Medical sciences | Pneumology | Phosphodiesterase Inhibitors - therapeutic use | Sulfones - therapeutic use | Thiophenes - therapeutic use | Humans | Hypertension, Pulmonary - physiopathology | Piperazines - therapeutic use | Eisenmenger Complex - physiopathology | Antihypertensive Agents - therapeutic use | Sildenafil Citrate | Epoprostenol - therapeutic use | Epoprostenol - analogs & derivatives | Sulfonamides - therapeutic use | Eisenmenger Complex - drug therapy | Hypertension, Pulmonary - drug therapy | Pulmonary Circulation - drug effects | Purines - therapeutic use | Isoxazoles - therapeutic use | Endothelin Receptor Antagonists | Heart failure | Anticoagulants | Life expectancy | Pulmonary arteries | Surgery | Medical prognosis | Mortality | Flow velocity | Thrombosis | Pulmonary hypertension | Defects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights